Article

Silicone hydrogel lens sales soared during 2005

Atlanta?Silicone hydrogel contact lens sales are speeding up so rapidly that they may overtake traditional soft contact lens sales by the end of 2007, according to estimates based on retail audit data by the A.C. Nielsen Co. CIBA Vision holds the leading share of the silicone hydrogel segment at 49.5% of retail sales year-to-date, August 2005, according to the data.

Atlanta-Silicone hydrogel contact lens sales are speeding up so rapidly that they may overtake traditional soft contact lens sales by the end of 2007, according to estimates based on retail audit data by the A.C. Nielsen Co. CIBA Vision holds the leading share of the silicone hydrogel segment at 49.5% of retail sales year-to-date, August 2005, according to the data.

"As more silicone hydrogel lenses are introduced, we are witnessing an acceleration of eye-care professionals converting to these advanced materials," said Karen Gough, president, CIBA Vision's Americas Region.

"If present trends continue, silicone hydrogels will become the dominant lens material in the United States during 2007, ahead of our prior forecasts," she continued.

Since September 2004, when CIBA Vision introduced its 2-week silicone hydrogel lens, O2OPTIX, the silicone hydrogel segment's share of retail sales has grown on an average of 1.2 points per month. By year-end 2006, the segment's share is likely to exceed 45%.

Related Videos
Arun Gulani, MD: How the Gni instrument enhances precision and control in cataract surgery
EyeCon 2024: Peter J. McDonnell, MD, marvels on mentoring, modern technology, and ophthalmology’s future
EyeCon Co-chair Oluwatosin U. Smith, MD: Passion for Research and Education Drives Her Commitment to Ophthalmology
Dr. SriniVas Sadda Discusses Vision for ARVO as New President: Collaboration, Funding Challenges, and Impact of Annual Meetings
Highlights from the 18th Annual Controversies in Modern Eye Care Symposium: Arjan Hura, MD, on Refractive Surgery, Retina Care, and Record Attendance
ASCRS 2024: ViaLase Updates on Nonincisional Glaucoma Treatment Targeting Trabecular Meshwork
Dr. Neda Nikpoor Shares Practical Techniques to Combat Unconscious Gender Bias and Promote Gender Equality in Ophthalmology
ASCRS 2024: George O. Waring, MD, shares early clinical performance of bilateral Odyssey implantation
ASCRS 2024: Deborah Gess Ristvedt, DO, discusses third-generation trabecular micro-bypass
© 2024 MJH Life Sciences

All rights reserved.